Previous Close | 8.45 |
Open | 0.00 |
Bid | 7.85 x N/A |
Ask | 8.30 x N/A |
Day's Range | 0.00 - 0.00 |
52 Week Range | |
Volume | |
Avg. Volume | 0 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | Nov 06, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
LAFAYETTE, La., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three and nine months ended September 30, 2024. Operational highlights (all dollar amounts are USD; comparisons are to the period ended September 30, 2023 unless otherwise noted): Net revenues increased 17.4% for the quarte
As the U.S. stock market experiences a mixed performance with the S&P 500 and Dow Jones Industrial Average ending their six-week winning streaks, investors are keenly observing economic data and corporate earnings for signs of stability. In this environment, growth companies with substantial insider ownership can be particularly appealing, as such ownership often indicates confidence in the company's long-term prospects by those closest to its operations.